TY  - BOOK
ED  - United States.
TI  - Orange Book Transparency Act of 2019: report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office)
T2  - Report / 116th Congress, 1st session, House of Representatives
AV  - KF32 .E55 2019a
PY  - 2019///]
CY  - [Washington, D.C.]
PB  - [U.S. Government Publishing Office]
KW  - Pharmaceutical industry
KW  - United States
KW  - Drugs
KW  - Costs
KW  - Prescription pricing
KW  - Law and legislation
KW  - Generic substitution
KW  - Generic drugs
KW  - Competition
KW  - Legislative materials
KW  - lcgft
N1  - "May 2, 2019."; CRDP Program record; Includes bibliographical references
UR  - https://purl.fdlp.gov/GPO/gpo119882
ER  -